Literature DB >> 4030437

Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves.

B Fertil, E P Malaise.   

Abstract

One hundred and one published survival curves for 92 human cell lines (including 64 tumor lines) have been analyzed in terms of several parameters that are supposed to characterize cell radiosensitivity. Values for n, Do, alpha and beta (from the linear quadratic model), D (Mean Inactivation Dose), and survivals at 2 Gy and 8 Gy have been obtained for each curve. It was found that: I. the initial part of the survival curve is specific to the corresponding cell line; II. this initial part is well characterized by the parameters alpha and D, the values of which can be used to compare intrinsic radiosensitivity among human cell lines; III. human tumor cell line radiosensitivity (expressed in terms of alpha, D and survival at 2 Gy) reflects the clinical radioresponsiveness of the tumors from which the cell lines are derived. Thus, cells from tumors with low radioresponsiveness (melanomas and glioblastomas) are the less radiosensitive. Furthermore, the range of survival at a dose of 2 Gy is broad enough to account, in large measure, for observed differences in clinical tumor radioresponsiveness.

Entities:  

Mesh:

Year:  1985        PMID: 4030437     DOI: 10.1016/0360-3016(85)90223-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  75 in total

1.  Criteria and techniques for analysing cell survival data.

Authors:  D Bettega; P Calzolari; A Ottolenghi; L Tallone Lombardi
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

Review 2.  Less well known parameters of in vitro radiosensitivity.

Authors:  S Vijayakumar; T C Ng; I Koumoundouros; P D Higgins; F J Thomas
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

Review 3.  Genetic and epigenetic features in radiation sensitivity. Part II: implications for clinical practice and radiation protection.

Authors:  Michel H Bourguignon; Pablo A Gisone; Maria R Perez; Severino Michelin; Diana Dubner; Marina Di Giorgio; Edgardo D Carosella
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 9.236

4.  Modeling Cellular Response in Large-Scale Radiogenomic Databases to Advance Precision Radiotherapy.

Authors:  Venkata Sk Manem; Meghan Lambie; Ian Smith; Petr Smirnov; Victor Kofia; Mark Freeman; Marianne Koritzinsky; Mohamed E Abazeed; Benjamin Haibe-Kains; Scott V Bratman
Journal:  Cancer Res       Date:  2019-09-26       Impact factor: 12.701

5.  Role of transfection and clonal selection in mediating radioresistance.

Authors:  F S Pardo; R G Bristow; A Taghian; A Ong; C Borek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

6.  Primary intracerebral osteosarcoma: a case report.

Authors:  G S Bauman; W M Wara; S F Ciricillo; R L Davis; S Zoger; M S Edwards
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

7.  Role of transcriptional corepressor CtBP1 in prostate cancer progression.

Authors:  Rui Wang; Irfan A Asangani; Balabhadrapatruni V S K Chakravarthi; Bushra Ateeq; Robert J Lonigro; Qi Cao; Ram-Shankar Mani; Daniel F Camacho; Natalie McGregor; Taibriana E W Schumann; Xiaojun Jing; Radhika Menawat; Scott A Tomlins; Heng Zheng; Arie P Otte; Rohit Mehra; Javed Siddiqui; Saravana M Dhanasekaran; Mukesh K Nyati; Kenneth J Pienta; Nallasivam Palanisamy; Lakshmi P Kunju; Mark A Rubin; Arul M Chinnaiyan; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

8.  Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy.

Authors:  Denise Bernhardt; Sebastian Adeberg; Farastuk Bozorgmehr; Nils Opfermann; Juliane Hoerner-Rieber; Laila König; Jutta Kappes; Michael Thomas; Felix Herth; Claus Peter Heußel; Arne Warth; Jürgen Debus; Martin Steins; Stefan Rieken
Journal:  J Neurooncol       Date:  2017-05-30       Impact factor: 4.130

9.  Comparison of cellular radiosensitivity between different localizations of head and neck squamous-cell carcinoma.

Authors:  K Pekkola-Heino; M Jaakkola; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

10.  In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.

Authors:  Marion T Weigel; Linda Dahmke; Christian Schem; Dirk O Bauerschlag; Katrin Weber; Peter Niehoff; Maret Bauer; Alexander Strauss; Walter Jonat; Nicolai Maass; Christoph Mundhenke
Journal:  BMC Cancer       Date:  2010-08-09       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.